554 



SUBJECT INDEX 



concentration, method of expression, 2 



nuclear, 

 amount of, 123-124 

 distribution of, 124 

 percentage of, 122-123 

 state of, 124 



protein and, 95 



tissue content, 8-15 

 Deoxyribonucleosides, degradation of, 



267 

 Deoxyribose, 310 



fermentation of, 271 



formation from ribose, 327, 350 



gluconate and, 261 



nucleic acid estimation and, 157, 160- 

 161 



transglycosidases and, 319 

 Deoxyribose-1 -phosphate, 



conversion to 5-phosphate, 267 



deoxyriboside phosphorylase and, 315, 

 318 



nucleoside phosphorylase and, 337 



transglycosidases and, 319 

 Deoxyribose-5-phosphate, 



nucleoside synthesis and, 263 



synthesis of, 263, 267 

 Deoxyribose phosphate aldolase, charac- 

 terization of, 263 

 Deoxyribosides, 



cytoplasmic, 387-388 



formation of, 382-383 



incorporation of, 196-197, 326 



requirement for, 319 



vitamin B12 and, 334 

 Deoxysugars, aldehydes and, 68 

 Depolymerization, 



methyl green and, 59 



ultraviolet absorption and, 84 

 Dextran, 109 

 Diabetes, 



alloxan, nucleic acids and, 36, 38 



mitochondria and, 243 

 Diadenosine tetraphosphate, polynu- 

 cleotide synthesis and, 388 

 2,6-Diaminopurine, 



deamination of, 383 



formate incorporation and, 378 



incorporation of, 347, 353, 384 



nucleoside phosphorylase and, 384 



purine interconversion and, 294, 348, 

 354:-355, 382 



reversal, adenosine-3'-phosphate and, 



386 

 transglycosidase and, 320 

 utilization, 385 

 2,6-Diaminopurine riboside, 



adenosine phosphokinase and, 329 

 catabolism of, 383 

 incorporation of, 326, 348 

 interconversions of, 385-386 

 phosphorylation of, 382, 384 

 2,6-Diaminopurine ribotide, 392 

 formation of, 389 

 guanylic deaminase and, 323 

 2,6-Diaminopyrimidine, incorporation 



of, 349 

 Diaphorase, nuclei and, 135 

 1,2,5,6-Dibenzanthracene, nucleic acid 



ratios and, 31 

 Diet, 



deoxyribonucleic acid and, 123, 168 

 microsomes and, 505-506 

 pentose nucleic acid, 489-490 

 phosphate, 402, 412 

 renewal, 357 

 tissue nucleic acids and, 22-23, 24-27, 

 49, 125, 127 

 Diethylsafranine, mitochondria and, 213 

 Differentiation, 

 controlled destaining and, 61 

 deoxyribonucleic acid and, 176 

 factors affecting, 60 

 Dihydroorotase, orotic acid synthesis 



and, 306 

 Dihydroorotic acid, 

 orotic acid degradation and, 303 

 pyrimidine synthesis and, 338 

 synthesis of, 302, 306 

 Dihydroorotic dehydrogenase, orotic 



acid synthesis and, 306 

 Dihydroxyacetone, sedoheptulose and, 



253 

 Dihydroxyacetone phosphate, 

 pentose synthesis and, 262, 266 

 reduction, 227 

 Dihydroxymaleic acid, 



active glycolaldehyde and, 252 

 pentose synthesis and, 263 

 4-Dimethylaminoazobenzene, carcino- 

 genesis and, 30 



